CergenX has developed a medical device to identify newborns who are most at risk of brain injury. CergenX Wave uses AI to swiftly and accurately assess newborn brain function, bringing specialist-level EEG insights directly to clinicians at the point of care. This advancement in diagnostic support promotes timely and equitable care for all newborns.